金斯瑞生物科技(01548.HK)：联营传奇生物任命孟建革为董事

Core Viewpoint - Kingsray Biotechnology (01548.HK) announced the appointment of Meng Jiange as a director of Legend Biotech Corporation, effective from January 20, 2026, replacing Zhu Li who will resign on the same date [1]. Group 1 - Kingsray Biotechnology is a company that has a joint venture with Legend Biotech Corporation, which is listed on the NASDAQ Global Select Market [1]. - The appointment of Meng Jiange is part of the governance changes within the board of Legend Biotech [1]. - Zhu Li will step down from the board on the effective date, indicating a transition in leadership [1].